Evidence map›Paper›PMID 34649334›Full record

SynthesisBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2021

Nanoparticles as an effective drug delivery system in COVID-19.

Neehasri Kumar Chowdhury, Deepika, Reshma Choudhury, Gaurav Ambadas Sonawane, Shankar Mavinamar, Xiaoming Lyu, Ramendra Pati Pandey, Chung-Ming Chang

RetractedAbstract readSystematic ReviewRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Neehasri Kumar ChowdhuryDepartment of Zoology, Gauhati University, Guwahati, Assam, India. Electronic address: neehasri1234@gmail.com.
DeepikaDepartment of Biotechnology, Deenbandhu Choturam University, and Technology, Sonepat, Haryana, India. Electronic address: deepikagahlot51@gmail.com.
Reshma ChoudhuryDepartment of Biotechnology, Royal Global University, Guwahati, Assam, India. Electronic address: reshmachoudhury198@gmail.com.
Gaurav Ambadas SonawaneDepartment of Pharmacy, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, India. Electronic address: sonawanegaurav8888@gmail.com.
Shankar MavinamarDepartment of Botany, Karnataka State Akkamahadevi Women's University, Vijayapura, India. Electronic address: shankarm050@gmail.com.
Xiaoming LyuLaboratory Medicine, The Third Affiliated Hospital, Southern Medical University, No.183 West Zhongshan Avenue, Guangzhou, China. Electronic address: xiaomlyu@smu.edu.cn.
Ramendra Pati PandeyDepartment of Biotechnology, SRM University, Delhi-NCR, Sonepat, India. Electronic address: ramendra.pandey@srmuniversity.ac.in.
Chung-Ming ChangMaster & Ph.D. program in Biotechnology Industry, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan City 33302, Taiwan, ROC.. Electronic address: cmchang@mail.cgu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nanoparticle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles.

objectiveThe main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19.

methodsThe bibliographic search was done through a systematic search. The terms "Nanoparticles", "Covid-19 ", "Drug delivery" etc. were used to search the databases/search engines like "Google Scholar", "NCBI", "PubMed", "Science Direct" etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report.

conclusionOur current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects.

Indexed as

COVID-19 Drug TreatmentNanoparticlesAnimalsBiopolymersCOVID-19Drug Delivery SystemsHumansNanomedicineSARS-CoV-2BiopolymersBibliographic searchCovid-19Drug delivery systemNanoparticlesTreatment

Identifiers

PMID34649334
PMCPMC8426213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.